| abstract |
A series of compounds having heterocyclo alkyl structures, isomers or pharmaceutically acceptable salts thereof, and an application thereof in preparing medicines for treatment of diseases related to CCR2/CCR5 antagonist. The present invention in particular discloses a compound represented in formula (I) or pharmaceutically acceptable salts, isomers or pharmaceutically acceptable salts thereof. |